CEPORACIN DIN 02060051
Status: Cancelled Post Market
Holder: MYLAN PHARMACEUTICALS ULC
Molecule: CEPHALOTHIN (CEPHALOTHIN SODIUM)
Health Canada record
| Active ingredient(s) | CEPHALOTHIN (CEPHALOTHIN SODIUM) 1 G |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intravenous; Intramuscular |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J01DB03 CEFALOTIN |
| Original market date | 31-Dec-1994 |
| Current status date | 03-Nov-2015 |
| Source | Health Canada DPD |
Establishment licence of the holder
Mylan Pharmaceuticals ULC — licence 101774, currently licensed, last inspection rating C (2026-02-24).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CEPHALOTHIN (CEPHALOTHIN SODIUM)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00752525 | KEFLIN ADD-VANTAGE INJ 1GM/VIAL | ELI LILLY CANADA INC | Liquid | CEPHALOTHIN (CEPHALOTHIN SODIUM) 1 G | Cancelled Post Market |
| 00015369 | KEFLIN NEUTRAL INJ 1GM | ELI LILLY CANADA INC | Powder For Solution | CEPHALOTHIN (CEPHALOTHIN SODIUM) 1 G | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 15480 | 2014-04-02 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |